Research location

Zwickau

Germany

Published trials36

Site observations49

Linked trials published36

Page1 / 1

Research activity in Zwickau

Germany

CureCurrent currently publishes aggregate city-level research activity for this location: 36 trials and 49 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Zwickau

36 linked trials · page 1 of 1

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation

A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)NCT06780150 · 2024-09-26 · 1 site observation

NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic AlterationsNCT06494540 · 2024-06-28 · 1 site observation

NeoRad Breast Cancer StudyNCT04261244 · 2024-02-01 · 1 site observation

BAROSTIM THERAPY™ In Resistant HypertensionNCT02880631 · 2016-12-13 · 1 site observation

An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid ArthritisNCT04267536 · 2020-02-06 · 1 site observation

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart FailureNCT03494933 · 2018-09-01 · 1 site observation

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisNCT03387423 · 2017-11-02 · 1 site observation

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU CountriesNCT02632890 · 2016-11-29 · 2 site observations

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast CancerNCT02474641 · 2015-06-16 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.NCT02486302 · 2015-03-24 · 1 site observation

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular LeadsNCT02290028 · 2014-12-16 · 1 site observation

Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)NCT02077634 · 2014-05-01 · 1 site observation

Azilect® In Wearing-Off (AIWO)NCT02384512 · 2014-01-01 · 1 site observation

Hypofractionation With Simultaneous Integrated Boost for Early Breast CancerNCT01948726 · 2013-12-01 · 1 site observation

Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation

Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) InhibitorsNCT01764321 · 2012-12-01 · 1 site observation

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of CancerNCT01614002 · 2012-05-01 · 1 site observation

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)NCT01585298 · 2012-04-29 · 1 site observation

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With DepressionNCT01436643 · 2011-11-01 · 1 site observation

Ingenio Device Algorithm StudyNCT01441583 · 2011-10-01 · 1 site observation

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)NCT01285167 · 2010-08-01 · 1 site observation

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 6 site observations

Safety and Clinical Performance of the Protecta ICD and CRT-DNCT00982397 · 2009-09-01 · 1 site observation

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01 · 1 site observation

Intermittent Treatment With Degarelix of Patients Suffering From Prostate CancerNCT00801242 · 2008-12-01 · 1 site observation

Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's DiseaseNCT00752388 · 2008-11-01 · 1 site observation

Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation

Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 7 site observations

Transdermal Rotigotine User Surveillance StudyNCT00599339 · 2006-06-01 · 1 site observation

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])NCT00273338 · 2006-01-01 · 1 site observation

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsNCT00252863 · 2004-12-01 · 1 site observation

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeNCT01077258 · 2004-04-01 · 2 site observations

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation

Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityNCT00274573 · 2002-03-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.